Researchers have discovered a way to make neurons respond to placebos. They believe the findings could be used as a potential treatment for Parkinson's disease.
A new study reveals deep brain stimulation helps reduce excessive synchronization of brain activity in the motor cortex of Parkinson's patients.
Researchers use RNAi to reveal dozens of genes which could represent new therapeutic targets for treating Parkinson's disease.
Researchers have identified biomarkers that can help predict which patients with Parkinson's disease will suffer from significant cognitive deficits within three years of diagnosis.
Zolpidem, a medication commonly prescribed for insomnia, appear to be effective in helping to restore a conscious state in some patients who were in comas or vegetative state.
Researchers have created a two photon flurogenic probe which could be a useful tool to assess a person's potential risk of developing Parkinson's disease and to track the diseases progression.
Researchers discover a link between neural tube defects and neurodegenerative diseases.
Inflammation of the colon is associated with alterations in alpha-synuclein expression and phosphorylation in the myenteric plexus of common marmoset monkeys. The findings support the growing body of evidence that inflammation may play a role in the development of Parkinson's disease.
Researchers measure dopamine release during surgery in Parkinson's patients and identify how rapid dopamine release encodes information critical to learning and decision making.